vs
Organogenesis Holdings Inc.(ORGO)与Resolute Holdings Management, Inc.(RHLD)财务数据对比。点击上方公司名可切换其他公司
Organogenesis Holdings Inc.的季度营收约是Resolute Holdings Management, Inc.的1.9倍($225.6M vs $117.7M),Organogenesis Holdings Inc.净利率更高(19.4% vs -1.5%,领先20.8%),Resolute Holdings Management, Inc.自由现金流更多($189.2M vs $34.8M)
Organogenesis Holdings Inc.是一家领先的再生医学企业,专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品,主要服务美国及部分国际市场的医疗机构与患者,提供经临床验证的医疗解决方案。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业,核心业务布局于非洲地区,目前运营两座金矿,分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿,专注于黄金资源的勘探、开采及相关运营管理工作。
ORGO vs RHLD — 直观对比
营收规模更大
ORGO
是对方的1.9倍
$117.7M
净利率更高
ORGO
高出20.8%
-1.5%
自由现金流更多
RHLD
多$154.5M
$34.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $225.6M | $117.7M |
| 净利润 | $43.7M | $-1.7M |
| 毛利率 | — | 55.7% |
| 营业利润率 | 28.1% | 30.2% |
| 净利率 | 19.4% | -1.5% |
| 营收同比 | 78.1% | — |
| 净利润同比 | 469.5% | — |
| 每股收益(稀释后) | $0.31 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ORGO
RHLD
| Q4 25 | $225.6M | $117.7M | ||
| Q3 25 | $150.9M | $120.9M | ||
| Q2 25 | $101.0M | $119.6M | ||
| Q1 25 | $86.7M | $103.9M | ||
| Q4 24 | $126.7M | — | ||
| Q3 24 | $115.2M | — | ||
| Q2 24 | $130.2M | — | ||
| Q1 24 | $110.0M | — |
净利润
ORGO
RHLD
| Q4 25 | $43.7M | $-1.7M | ||
| Q3 25 | $21.6M | $-231.0K | ||
| Q2 25 | $-9.4M | $-611.0K | ||
| Q1 25 | $-18.8M | $-3.4M | ||
| Q4 24 | $7.7M | — | ||
| Q3 24 | $12.3M | — | ||
| Q2 24 | $-17.0M | — | ||
| Q1 24 | $-2.1M | — |
毛利率
ORGO
RHLD
| Q4 25 | — | 55.7% | ||
| Q3 25 | — | 59.0% | ||
| Q2 25 | — | 57.5% | ||
| Q1 25 | 72.6% | 52.5% | ||
| Q4 24 | 75.5% | — | ||
| Q3 24 | 76.7% | — | ||
| Q2 24 | 77.6% | — | ||
| Q1 24 | 73.9% | — |
营业利润率
ORGO
RHLD
| Q4 25 | 28.1% | 30.2% | ||
| Q3 25 | 13.7% | 34.3% | ||
| Q2 25 | -12.5% | 34.0% | ||
| Q1 25 | -30.9% | 24.7% | ||
| Q4 24 | 8.1% | — | ||
| Q3 24 | 5.4% | — | ||
| Q2 24 | -10.7% | — | ||
| Q1 24 | -3.5% | — |
净利率
ORGO
RHLD
| Q4 25 | 19.4% | -1.5% | ||
| Q3 25 | 14.3% | -0.2% | ||
| Q2 25 | -9.3% | -0.5% | ||
| Q1 25 | -21.7% | -3.2% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 10.7% | — | ||
| Q2 24 | -13.1% | — | ||
| Q1 24 | -1.9% | — |
每股收益(稀释后)
ORGO
RHLD
| Q4 25 | $0.31 | $-0.20 | ||
| Q3 25 | $0.11 | $-0.03 | ||
| Q2 25 | $-0.10 | $-0.07 | ||
| Q1 25 | $-0.17 | $-0.39 | ||
| Q4 24 | $0.05 | — | ||
| Q3 24 | $0.09 | — | ||
| Q2 24 | $-0.13 | — | ||
| Q1 24 | $-0.02 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $93.7M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $300.1M | $6.5M |
| 总资产 | $598.7M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势,按日历期对齐
现金及短期投资
ORGO
RHLD
| Q4 25 | $93.7M | $205.5M | ||
| Q3 25 | $63.7M | $148.0M | ||
| Q2 25 | $73.1M | $99.9M | ||
| Q1 25 | $110.0M | $71.0M | ||
| Q4 24 | $135.6M | — | ||
| Q3 24 | $94.3M | — | ||
| Q2 24 | $89.9M | — | ||
| Q1 24 | $88.6M | — |
总债务
ORGO
RHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | $62.3M | — | ||
| Q2 24 | $63.8M | — | ||
| Q1 24 | $65.2M | — |
股东权益
ORGO
RHLD
| Q4 25 | $300.1M | $6.5M | ||
| Q3 25 | $255.1M | $10.8M | ||
| Q2 25 | $233.2M | $9.6M | ||
| Q1 25 | $242.9M | $8.9M | ||
| Q4 24 | $262.9M | — | ||
| Q3 24 | $278.5M | — | ||
| Q2 24 | $263.5M | — | ||
| Q1 24 | $278.0M | — |
总资产
ORGO
RHLD
| Q4 25 | $598.7M | $333.4M | ||
| Q3 25 | $509.8M | $293.2M | ||
| Q2 25 | $461.1M | $253.3M | ||
| Q1 25 | $467.4M | $214.3M | ||
| Q4 24 | $497.9M | — | ||
| Q3 24 | $446.3M | — | ||
| Q2 24 | $443.2M | — | ||
| Q1 24 | $458.5M | — |
负债/权益比
ORGO
RHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.22× | — | ||
| Q2 24 | 0.24× | — | ||
| Q1 24 | 0.23× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $39.4M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | $34.8M | $189.2M |
| 自由现金流率自由现金流/营收 | 15.4% | 160.8% |
| 资本支出强度资本支出/营收 | 2.1% | 5.8% |
| 现金转化率经营现金流/净利润 | 0.90× | — |
| 过去12个月自由现金流最近4个季度 | $-24.5M | $313.2M |
8季度趋势,按日历期对齐
经营现金流
ORGO
RHLD
| Q4 25 | $39.4M | $196.1M | ||
| Q3 25 | $3.1M | $59.6M | ||
| Q2 25 | $-32.9M | $48.9M | ||
| Q1 25 | $-19.9M | $18.4M | ||
| Q4 24 | $10.9M | — | ||
| Q3 24 | $8.7M | — | ||
| Q2 24 | $4.7M | — | ||
| Q1 24 | $-10.2M | — |
自由现金流
ORGO
RHLD
| Q4 25 | $34.8M | $189.2M | ||
| Q3 25 | $844.0K | $58.6M | ||
| Q2 25 | $-36.5M | $47.5M | ||
| Q1 25 | $-23.6M | $17.8M | ||
| Q4 24 | $7.6M | — | ||
| Q3 24 | $6.1M | — | ||
| Q2 24 | $2.9M | — | ||
| Q1 24 | $-12.4M | — |
自由现金流率
ORGO
RHLD
| Q4 25 | 15.4% | 160.8% | ||
| Q3 25 | 0.6% | 48.5% | ||
| Q2 25 | -36.1% | 39.7% | ||
| Q1 25 | -27.2% | 17.1% | ||
| Q4 24 | 6.0% | — | ||
| Q3 24 | 5.3% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | -11.3% | — |
资本支出强度
ORGO
RHLD
| Q4 25 | 2.1% | 5.8% | ||
| Q3 25 | 1.5% | 0.8% | ||
| Q2 25 | 3.6% | 1.2% | ||
| Q1 25 | 4.2% | 0.6% | ||
| Q4 24 | 2.7% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 1.4% | — | ||
| Q1 24 | 2.0% | — |
现金转化率
ORGO
RHLD
| Q4 25 | 0.90× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 0.71× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图